生物活性 | |||
---|---|---|---|
描述 | Roluperidone (CYR-101), a novel cyclic amide compound, exhibits high and equal potency for 5-HT2A and sigma-2 receptors, with binding constants (Ki) of 7.53 nM for 5-HT2A and 8.19 nM for sigma-2 receptors[1]. Roluperidone (CYR-101) demonstrates affinity to α1-adrenergic receptors, showing minimal to negligible binding to muscarinic, cholinergic, and histaminergic receptors. Despite lacking affinity for both pre- and postsynaptic dopaminergic receptors, Roluperidone (CYR-101) is likely involved in the regulation of dopamine and glutamatergic signaling pathways through sigma-2 receptor interaction, also affecting neuronal calcium modulation[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.73mL 0.55mL 0.27mL |
13.65mL 2.73mL 1.36mL |
27.29mL 5.46mL 2.73mL |
参考文献 |
---|